グリコピロニウム (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "グリコピロニウム" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

2blackwell-synergy.com

low place

low place

2chestjournal.org

low place

low place

3,257^th place

6,629^th place

low place

low place

610^th place

915^th place

1ersjournals.com

low place

low place

6,690^th place

394^th place

low place

low place

ama-assn.org

archpedi.ama-assn.org

Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M (December 2000). “Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study”. Arch Pediatr Adolesc Med 154 (12): 1214–8. doi:10.1001/archpedi.154.12.1214. PMID 11115305.

blackwell-synergy.com

chestjournal.org

doi.org

elsevier.com

linkinghub.elsevier.com

Olsen AK, Sjøgren P (October 1999). “Oral glycopyrrolate alleviates drooling in a patient with tongue cancer”. J Pain Symptom Manage 18 (4): 300–2. doi:10.1016/S0885-3924(99)00080-9. PMID 10534970.

ersjournals.com

erj.ersjournals.com

Tzelepis G, Komanapolli S, Tyler D, Vega D, Fulambarker A (January 1996). “Comparison of nebulized glycopyrrolate and metaproterenol in chronic obstructive pulmonary disease”. Eur. Respir. J. 9 (1): 100–3. doi:10.1183/09031936.96.09010100. PMID 8834341.

eymj.org

Kim WO, Kil HK, Yoon DM, Cho MJ (August 2003). “Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate” (^{[リンク切れ]}). Yonsei Med. J. 44 (4): 579–82. PMID 12950111.

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

Haddad EB, Patel H, Keeling JE, Yacoub MH, Barnes PJ, Belvisi MG (May 1999). “Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways”. Br. J. Pharmacol. 127 (2): 413–20. doi:10.1038/sj.bjp.0702573. PMC 1566042. PMID 10385241.

pmda.go.jp

info.pmda.go.jp

“シーブリ吸入用カプセル50µg 添付文書” (2016年9月). 2016年11月4日閲覧。^{[リンク切れ]}

theannals.com

Tscheng DZ (November 2002). “Sialorrhea - therapeutic drug options”. Ann Pharmacother 36 (11): 1785–90. doi:10.1345/aph.1C019. PMID 12398577.